321 related articles for article (PubMed ID: 21160904)
1. Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.
Cardinale V; Semeraro R; Torrice A; Gatto M; Napoli C; Bragazzi MC; Gentile R; Alvaro D
World J Gastrointest Oncol; 2010 Nov; 2(11):407-16. PubMed ID: 21160904
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.
Alvaro D; Bragazzi MC; Benedetti A; Fabris L; Fava G; Invernizzi P; Marzioni M; Nuzzo G; Strazzabosco M; Stroffolini T;
Dig Liver Dis; 2011 Jan; 43(1):60-5. PubMed ID: 20580332
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.
Khan SA; Toledano MB; Taylor-Robinson SD
HPB (Oxford); 2008; 10(2):77-82. PubMed ID: 18773060
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
5. Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity.
Cardinale V; Carpino G; Reid L; Gaudio E; Alvaro D
World J Gastrointest Oncol; 2012 May; 4(5):94-102. PubMed ID: 22645632
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of cholangiocarcinoma.
Bergquist A; von Seth E
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma: increasing burden of classifications.
Cardinale V; Bragazzi MC; Carpino G; Torrice A; Fraveto A; Gentile R; Pasqualino V; Melandro F; Aliberti C; Bastianelli C; Brunelli R; Berloco PB; Gaudio E; Alvaro D
Hepatobiliary Surg Nutr; 2013 Oct; 2(5):272-80. PubMed ID: 24570958
[TBL] [Abstract][Full Text] [Related]
8. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.
Bragazzi MC; Ridola L; Safarikia S; Matteo SD; Costantini D; Nevi L; Cardinale V
Ann Gastroenterol; 2018; 31(1):42-55. PubMed ID: 29333066
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma.
Yata M; Suzuki K; Furuhashi N; Kawakami K; Kawai Y; Naganawa S
Clin Radiol; 2016 Mar; 71(3):203-10. PubMed ID: 26703117
[TBL] [Abstract][Full Text] [Related]
11. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune Hepatitis: A Risk Factor for Cholangiocarcinoma.
Garg R; Khan U; AlRajjal A; Kafri Z
Case Rep Gastroenterol; 2017; 11(3):672-677. PubMed ID: 29282390
[TBL] [Abstract][Full Text] [Related]
13. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Risk Factors of Cholangiocarcinoma.
Kirstein MM; Vogel A
Visc Med; 2016 Dec; 32(6):395-400. PubMed ID: 28229073
[TBL] [Abstract][Full Text] [Related]
15. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.
Lee JJ; Schindera ST; Jang HJ; Fung S; Kim TK
Abdom Radiol (NY); 2017 Dec; 42(12):2898-2908. PubMed ID: 28951947
[TBL] [Abstract][Full Text] [Related]
17. Transplantation for cholangiocarcinoma.
Masuoka HC; Rosen CB
Clin Liver Dis; 2011 Nov; 15(4):699-715. PubMed ID: 22032524
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
[TBL] [Abstract][Full Text] [Related]
19. Cell of origin in biliary tract cancers and clinical implications.
Moeini A; Haber PK; Sia D
JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma--current treatment options.
Friman S
Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]